These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26446053)

  • 1. Assessment of nucleic acid modification induced by amotosalen and ultraviolet A light treatment of platelets and plasma using real-time polymerase chain reaction amplification of variable length fragments of mitochondrial DNA.
    Bakkour S; Chafets DM; Wen L; Dupuis K; Castro G; Green JM; Stassinopoulos A; Busch MP; Lee TH
    Transfusion; 2016 Feb; 56(2):410-20. PubMed ID: 26446053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymerase chain reaction inhibition assay documenting the amotosalen-based photochemical pathogen inactivation process of platelet concentrates.
    Bruchmüller I; Janetzko K; Bugert P; Mayaudon V; Corash L; Lin L; Klüter H
    Transfusion; 2005 Sep; 45(9):1464-72. PubMed ID: 16131379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the psoralen-based photochemical pathogen inactivation on mitochondrial DNA in platelets.
    Bruchmüller I; Lösel R; Bugert P; Corash L; Lin L; Klüter H; Janetzko K
    Platelets; 2005 Dec; 16(8):441-5. PubMed ID: 16287610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial DNA multiplex real-time polymerase chain reaction inhibition assay for quality control of pathogen inactivation by ultraviolet C light in platelet concentrates.
    Kim S; Handke W; Gravemann U; Döscher A; Brixner V; Müller TH; Seltsam A
    Transfusion; 2018 Mar; 58(3):758-765. PubMed ID: 29282743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amotosalen interactions with platelet and plasma components: absence of neoantigen formation after photochemical treatment.
    Lin L; Conlan MG; Tessman J; Cimino G; Porter S
    Transfusion; 2005 Oct; 45(10):1610-20. PubMed ID: 16181212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photochemical treatment of platelet concentrates with amotosalen hydrochloride and ultraviolet A light inactivates free and latent cytomegalovirus in a murine transfusion model.
    Jordan CT; Saakadze N; Newman JL; Lezhava LJ; Maiers TT; Hillyer WM; Roback JD; Hillyer CD
    Transfusion; 2004 Aug; 44(8):1159-65. PubMed ID: 15265119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
    Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
    Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photochemical inactivation with amotosalen and long-wavelength ultraviolet light of Plasmodium and Babesia in platelet and plasma components.
    Grellier P; Benach J; Labaied M; Charneau S; Gil H; Monsalve G; Alfonso R; Sawyer L; Lin L; Steiert M; Dupuis K
    Transfusion; 2008 Aug; 48(8):1676-84. PubMed ID: 18503613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a mitochondrial DNA real-time polymerase chain reaction assay for quality control of pathogen reduction with riboflavin and ultraviolet light.
    Bakkour S; Chafets DM; Wen L; van der Meer PF; Mundt JM; Marschner S; Goodrich RP; Busch MP; Lee TH
    Vox Sang; 2014 Nov; 107(4):351-9. PubMed ID: 24976130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light.
    Wagner SJ; Skripchenko A; Myrup A; Awatefe H; Thompson-Montgomery D; Moroff G; Carmichael P; Lin L
    Transfusion; 2009 Apr; 49(4):704-10. PubMed ID: 19171001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial.
    Pineda A; McCullough J; Benjamin RJ; Cable R; Strauss RG; Burgstaler E; Porter S; Lin L; Metzel P; Conlan MG;
    Transfusion; 2006 Apr; 46(4):562-71. PubMed ID: 16584432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inactivation of viruses in platelet concentrates by photochemical treatment with amotosalen and long-wavelength ultraviolet light.
    Lin L; Hanson CV; Alter HJ; Jauvin V; Bernard KA; Murthy KK; Metzel P; Corash L
    Transfusion; 2005 Apr; 45(4):580-90. PubMed ID: 15819680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Photochemical treatment of platelet concentrates with amotosalen and long-wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria.
    Lin L; Dikeman R; Molini B; Lukehart SA; Lane R; Dupuis K; Metzel P; Corash L
    Transfusion; 2004 Oct; 44(10):1496-504. PubMed ID: 15383024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen inactivation of double-dose buffy-coat platelet concentrates photochemically treated with amotosalen and UVA light: preservation of in vitro function.
    Sandgren P; Diedrich B
    Vox Sang; 2015 May; 108(4):340-9. PubMed ID: 25557354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The extent of amotosalen photodegradation during photochemical treatment of platelet components correlates with the level of pathogen inactivation.
    Liu W; Cimino GD; Corash L; Lin L
    Transfusion; 2011 Jan; 51(1):52-61. PubMed ID: 20663111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro photochemical inactivation of cell-associated human T-cell leukemia virus Type I and II in human platelet concentrates and plasma by use of amotosalen.
    Jauvin V; Alfonso RD; Guillemain B; Dupuis K; Fleury HJ
    Transfusion; 2005 Jul; 45(7):1151-9. PubMed ID: 15987361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amotosalen and ultraviolet A light efficiently inactivate MERS-coronavirus in human platelet concentrates.
    Hashem AM; Hassan AM; Tolah AM; Alsaadi MA; Abunada Q; Damanhouri GA; El-Kafrawy SA; Picard-Maureau M; Azhar EI; Hindawi SI
    Transfus Med; 2019 Dec; 29(6):434-441. PubMed ID: 31696565
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets photochemically treated with amotosalen HCl and ultraviolet A light correct prolonged bleeding times in patients with thrombocytopenia.
    Slichter SJ; Raife TJ; Davis K; Rheinschmidt M; Buchholz DH; Corash L; Conlan MG
    Transfusion; 2006 May; 46(5):731-40. PubMed ID: 16686840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of Zika virus in platelet components using amotosalen and ultraviolet A illumination.
    Santa Maria F; Laughhunn A; Lanteri MC; Aubry M; Musso D; Stassinopoulos A
    Transfusion; 2017 Aug; 57(8):2016-2025. PubMed ID: 28671343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical safety of platelets photochemically treated with amotosalen HCl and ultraviolet A light for pathogen inactivation: the SPRINT trial.
    Snyder E; McCullough J; Slichter SJ; Strauss RG; Lopez-Plaza I; Lin JS; Corash L; Conlan MG;
    Transfusion; 2005 Dec; 45(12):1864-75. PubMed ID: 16371039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.